Early epoetin for preventing red blood cell transfusion in premature infants

Source:
NICE Quality and Productivity Case Studies
Publisher:
Queen's University Belfast
Publication date:
23 April 2014

Abstract

Use of epoetin (also known as EPO) may reduce the use of blood transfusions but not sufficiently to reduce donor exposure. Use of epoetin appears to lead to an increase in the incidence of retinopathy of prematurity (ROP). As such the Cochrane review determined that the use of epoetin is not recommended.